We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning.
2014 was a watershed year for companies developing gene therapy and genome editing technologies, but 2015 is shaping up to be even better, according to speakers at this week's JP Morgan hea
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh